These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3276046)

  • 1. Cellular pathways for rejection of class-I-MHC--disparate skin and tumor allografts.
    Smith DM; Stuart FP; Wemhoff GA; Quintáns J; Fitch FW
    Transplantation; 1988 Jan; 45(1):168-75. PubMed ID: 3276046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype, specificity, and function of T cell subsets and T cell interactions involved in skin allograft rejection.
    Rosenberg AS; Mizuochi T; Sharrow SO; Singer A
    J Exp Med; 1987 May; 165(5):1296-315. PubMed ID: 2437237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effector cells in allelic H-2 class I-incompatible skin graft rejection.
    Ichikawa T; Nakayama E; Uenaka A; Monden M; Mori T
    J Exp Med; 1987 Oct; 166(4):982-90. PubMed ID: 3309129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
    Rosenberg AS; Mizuochi T; Singer A
    Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD8+ and CD4+ cells in islet allograft rejection.
    Yamamoto H; Monden M; Kawai M; Uenaka A; Gotoh M; Mori T; Sakurai M; Shiku H; Nakayama E
    Transplantation; 1990 Jul; 50(1):120-5. PubMed ID: 1973311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.
    Mizuochi T; Ono S; Malek TR; Singer A
    J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte subsets: major histocompatibility antigens rejection of H-2K or H-2I region disparate skin allografts by either Lyt-2+ or L3T4+ T-lymphocyte subset.
    Smith DM; McKisic M; Stuart FP; Fitch FW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):162-4. PubMed ID: 2650100
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of CD4+ and CD8+ cells in islet allo- and xeno-graft rejection.
    Gotoh M; Monden M; Yamamoto H; Kawai M; Ichikawa T; Mori T; Uenaka A; Nakayama E
    Horm Metab Res Suppl; 1990; 25():173-6. PubMed ID: 1982441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule.
    Dialynas DP; Quan ZS; Wall KA; Pierres A; Quintáns J; Loken MR; Pierres M; Fitch FW
    J Immunol; 1983 Nov; 131(5):2445-51. PubMed ID: 6415170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular stimuli for rejection of sarcoma I tumor allografts by BALB/c recipient mice.
    Smith DM; Fitch FW
    Cell Immunol; 1989 Feb; 118(2):358-67. PubMed ID: 2491961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of skin grafts and generation of cytotoxic T cells by mice depleted of L3T4+ cells.
    Woodcock J; Wofsy D; Eriksson E; Scott JH; Seaman WE
    Transplantation; 1986 Dec; 42(6):636-42. PubMed ID: 2947360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rejection of cultured thyroid allografts by the transfer of sensitized LYT 2+ T cells.
    Warren HS; Pembrey RG
    Transplantation; 1986 Apr; 41(4):421-6. PubMed ID: 3083539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of V beta+ T cells.
    Goss JA; Pyo R; Flye MW; Connolly JM; Hansen TH
    J Exp Med; 1993 Jan; 177(1):35-44. PubMed ID: 8418207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens.
    Sprent J; Schaefer M
    J Exp Med; 1985 Dec; 162(6):2068-88. PubMed ID: 2933483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R; Sprent J
    J Immunol; 1985 Nov; 135(5):3004-10. PubMed ID: 3876371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: evidence for tolerogenicity of donor resting B cells in vivo.
    Niimi M; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 1998 Dec; 66(12):1786-92. PubMed ID: 9884277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.